Gilead Sciences, Inc.
(NASDAQ : GILD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.17%171.671.3%$500.95m
BIIBBiogen Inc.
1.30%235.951.3%$485.51m
CELGCelgene Corporation
0.17%96.411.3%$469.40m
GILDGilead Sciences, Inc.
0.03%66.540.9%$452.29m
ILMNIllumina, Inc.
2.12%312.973.5%$316.36m
REGNRegeneron Pharmaceuticals, Inc.
3.01%319.282.6%$293.06m
AAgilent Technologies, Inc.
-0.32%68.101.6%$199.31m
VRTXVertex Pharmaceuticals Incorporated
2.45%173.261.9%$181.93m
EXASExact Sciences Corporation
-1.45%95.5425.3%$168.34m
ALXNAlexion Pharmaceuticals, Inc.
-0.66%127.952.0%$150.45m
BMRNBioMarin Pharmaceutical Inc.
0.38%87.804.3%$118.15m
SRPTSarepta Therapeutics, Inc.
0.59%121.9114.7%$116.17m
INCYIncyte Corporation
0.78%79.292.5%$107.57m
IONSIonis Pharmaceuticals, Inc.
-1.23%68.398.2%$98.13m
ALNYAlnylam Pharmaceuticals, Inc
0.62%68.299.2%$96.21m

Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. Its primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.